---
schema_version: "secwatch.filing_event.v1"
accession: "0000849146-22-000020"
form_type: "8-K"
ticker: "LFVN"
cik: "0000849146"
company_name: "Lifevantage Corp"
filed_at: "2022-03-11T23:59:59+00:00"
generated_at: "2026-06-26T23:45:46.178426+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# LifeVantage Chief Sales Officer Justin Rose departs effective March 7, 2022

## Summary
- Justin Rose's employment as Chief Sales Officer ended March 7, 2022.
- No reason for departure was disclosed in the filing.
- No replacement or interim appointment has been announced.

## SEC filing metadata
- accession: 0000849146-22-000020
- form_type: 8-K
- ticker: LFVN
- cik: 0000849146
- company_name: Lifevantage Corp
- filed_at: 2022-03-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/849146/000084914622000020/0000849146-22-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/849146/000084914622000020/lfvn-20220307.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000849146-22-000020
- JSON: https://secwatch.observer/filing/0000849146-22-000020.json
- Plain text: https://secwatch.observer/filing/0000849146-22-000020.txt

## Key facts
- Executive change
  Justin Rose departed as Chief Sales Officer at Lifevantage Corp.
  - Action: ended
  - Role: Chief Sales Officer
  source text: The employment of Justin Rose, LifeVantage Corporation’s Chief Sales Officer, ended effective on March 7, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/849146/000084914622000020/0000849146-22-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.